An examination of HIV/AIDS patients who have excellent adherence to HAART

An examination of HIV/AIDS patients who have excellent adherence to HAART
复制标题

DOI:
10.1080/0954012031000068399
复制
发表时间:
2003-04-01
影响因子:
1.7
通讯作者:
Stone, VE
Stone, VE
中科院分区:
医学4区
文献类型:
--
作者:
Malcolm, SE;Ng, JJ;Stone, VE

文献摘要

被引文献

相似文献

本文探讨了艾滋病毒/艾滋病患者的态度和信念,坚持高活性抗逆转录病毒治疗(HAART),以及他们如何不同于那些次优的坚持。44人与艾滋病毒/艾滋病,28名男性和16名女性,参加了一个定性的半结构化访谈,这是基于健康信念模式。主要结果是与该模型的几个维度一致的主题,反映了优秀坚持者与次优坚持者相比在健康相关态度和信念方面的差异。与依从性较差的患者相比,依从性良好的患者表达了以下主题:(1)认为依从率需要达到90-100%才能达到药物疗效;(2)非常信任他们的主要提供者;(3)即使在积极使用滥用药物时也会服用药物;(4)公开他们的HIV状态并获得大量的社会支持;(5)认为保持健康是他们的主要动力;(6)没有积极抑郁;所有人的CESD评分都正常。我们的研究表明,坚持高效抗逆转录病毒治疗的患者与坚持程度较低的患者在关键的健康相关态度和信念方面存在差异。识别和研究优秀的坚持者提供了新的见解和策略,以提高坚持HAART。
This paper examines the attitudes and beliefs of HIV/AIDS patients with excellent adherence to highly active antiretroviral therapy (HAART) and how they differ from those with suboptimal adherence. Forty-four persons with HIV/AIDS, 28 men and 16 women, participated in a qualitative semi-structured interview which was based on the Health Belief Model. The main outcomes were themes consistent with several dimensions of this model, reflecting differences in the health-related attitudes and beliefs of the excellent adherers compared to the suboptimal adherers. Patients with excellent adherence voiced the following themes when compared to less adherent patients: (1) believed adherence rates needed to be 90-100% for medication efficacy; (2) trusted their primary providers greatly; (3) took medications even when actively using substances of abuse; (4) were open about their HIV status and received substantial social support; (5) cited staying healthy as their key motivator; (6) were not actively depressed; all had normal CESD scores. Our study suggests that patients with excellent adherence to HAART differ from their less adherent counterparts in terms of key health-related attitudes and beliefs. Identifying and studying excellent adherers provides new insights and strategies for enhancing adherence to HAART.